{"id":3089,"date":"2022-03-30T10:08:44","date_gmt":"2022-03-30T10:08:44","guid":{"rendered":"https:\/\/linksus.net\/coronavirus-daily-news-updates-march-29-what-to-know-today-about-covid-19-in-the-seattle-area-washington-and-the-world-the-seattle-times\/"},"modified":"2022-03-30T10:08:44","modified_gmt":"2022-03-30T10:08:44","slug":"coronavirus-daily-news-updates-march-29-what-to-know-today-about-covid-19-in-the-seattle-area-washington-and-the-world-the-seattle-times","status":"publish","type":"post","link":"https:\/\/linksus2.linksus.net\/index.php\/2022\/03\/30\/coronavirus-daily-news-updates-march-29-what-to-know-today-about-covid-19-in-the-seattle-area-washington-and-the-world-the-seattle-times\/","title":{"rendered":"Coronavirus daily news updates, March 29: What to know today about COVID-19 in the Seattle area, Washington and the world – The Seattle Times"},"content":{"rendered":"

Editor\u2019s note:<\/em><\/strong> This is a live account of COVID-19 updates from Monday, March 29, as the day unfolded. It is no longer being updated. Click <\/em>here<\/em><\/a> to see all the most recent news about the pandemic, and <\/em>click here<\/em><\/a> to find additional resources.<\/em>
The Food and Drug Administration is expected to approve a second booster dose for people 50 years or older in an attempt to provide additional protection<\/a> to one of the groups most vulnerable to COVID-19.
Meanwhile, the Idaho Legislature passed a bill to would prohibit businesses from requiring a COVID-19 vaccination as a condition for employment or service and prevent unvaccinated people from being \u201cdiscriminated against.\u201d<\/a>
Some legislators criticized the bill, which would penalize business owners with a misdemeanor or $1,000 fine<\/a>, as being harmful to businesses already struggling under the pandemic, particularly small businesses.
We\u2019re updating this page with the latest news about the COVID-19 pandemic and its effects on the Seattle area, the U.S. and the world. Click here<\/a> to see the rest of our coronavirus coverage and here<\/a> to see how we track the daily spread across Washington.
More
We may be talking about a Russian military disaster now, but not so long ago, we were talking about a potential global health success for Russia. Just a year ago, Moscow\u2019s quickly approved coronavirus vaccine, Sputnik V, looked to be in ascendance, casting off initial Western skepticism. The respected British medical journal Lancet published a peer-reviewed paper that found the vaccine had high efficacy. Dozens of countries would go on to grant emergency approval to Sputnik V.
Global health experts celebrated. Cheaper and easier to store than some other vaccines, Sputnik V looked likely to fulfill an important international need. But it was also a diplomatic tool for the Kremlin. While the vaccine had been developed using adenovirus technology by the Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology, it was backed by the Russian Direct Investment Fund, a sovereign wealth fund.
One key aim appeared to be restoring international views of Russian scientific research, once lauded but in decline for decades. It wasn\u2019t subtle. The vaccine was named after the satellite that saw the Soviets beat the United States in the space race. But here could be a Russian triumph all of the world could share in: Kirill Dmitriev, RDIF chief executive, said there was the capacity to vaccinate 700 million people outside of Russia in 2021 alone.
Even then, however, not everyone was receptive. Ukrainian lawmakers approved a bill that officially banned vaccines made in Russia. The decision was at least partly based on geopolitical concerns: Moscow had already supplied the vaccine to the separatists it was backing in eastern Ukraine. Last year, when I asked Pavlo Kovtoniuk, Ukraine\u2019s deputy minister of health from 2016 to 2019, about the move, he said the health benefits of Sputnik V couldn\u2019t be separated from Ukraine\u2019s national security concerns about Russia.
Read the full story here.<\/a><\/em>
The European Union\u2019s drug regulator said Tuesday it has begun an accelerated review process for an experimental coronavirus vaccine booster made by the Spanish company Hipra.
The European Medicines Agency said in a statement that its evaluation is based on preliminary data from laboratory studies and research in adults that compared Hipra\u2019s booster shot to the vaccine made by Pfizer-BioNTech. It said early results suggest the immune response achieved with Hipra \u201cmay be effective\u201d against COVID-19, including the hugely infectious omicron variant.
Hipra is a protein-based vaccine and is made using similar technology as the Novavax COVID-19 vaccine, which was authorized by the EMA and other agencies in December.
Hipra is intended to be a booster shot in people who have been fully vaccinated with a messenger RNA vaccine or a vector-based vaccine, like the ones made by AstraZeneca and Johnson & Johnson. Until now, Hipra has mainly focused on making vaccines for animals.
Scientists believe using different types of vaccines can increase the body\u2019s immune response and numerous countries have adopted a \u201cmix-and-match\u201d strategy for COVID-19 vaccination.<\/p>\n

Read the story here.<\/a><\/em>
Vekile Sesha stood outside the rusted gates of a garment factory in the industrial district of Lesotho\u2019s capital, Maseru, willing her luck to change. Four months earlier, the blue jeans factory where she worked nearby abruptly shut, blaming plummeting demand from the Western brands it supplied amid the pandemic.
She had loved the job fiercely: \u201cI was talented, and I was doing something that was needed by the world.\u201d Her monthly paycheck of 2,400 loti (about $150) supported a constellation of family members in her rural village. \u201cBecause of me, they never slept on an empty stomach,\u201d she said.
Every day since, Sesha, 32, has been fighting to get that life back. On this morning, with a furious sun overhead, she joined a line of about 100 job-seekers outside the blue aluminum shell of a factory that supplies pants and athletic shirts to American chain stores.
As gates swung open, Sesha and the other women surged forward. A manager called out skills he needed: \u201cCutting. Sewing. Marking.\u201d But a few minutes later, the gates slammed shut and Sesha fell back \u2014 she did not get one of the temporary jobs.
When the coronavirus pandemic hit the world two years ago, the global fashion industry crumpled. Faced with collapsing demand, brands canceled orders worth billions of dollars and factories across Africa and Asia went belly up. Few felt the effects as harshly as the tens of millions of workers, most of them women, who stitched the world\u2019s clothes.
Read the full story here.<\/a><\/em>
Many Americans have taken significant steps back from once-routine coronavirus precautions, with less than half now saying they regularly wear face masks, avoid crowds and skip nonessential travel.
Americans are letting down their guard even as experts warn a new wave of COVID-19 cases is coming. A new poll from The Associated Press-NORC Center for Public Affairs Research shows fewer people taking protective measures than at any point in AP-NORC polls conducted since early 2021.
The poll found 44% say they often or always wear a face mask around people outside of their homes, down from 65% in January when infections of the highly contagious omicron variant were soaring. Just 40% say they\u2019re largely avoiding nonessential travel, compared with 60% in January. And 47% say they regularly stay away from large groups, down from 65% in January.
Most Americans say they at least sometimes still follow those safeguards. But they\u2019re increasingly returning to pre-pandemic norms as coronavirus infections have fallen to their lowest level since July.
Read the story here.<\/a><\/em>
Florida and 20 other states sued Tuesday to halt the federal government\u2019s requirement that people wear masks on planes, trains, ferries and other public transportation amid the coronavirus pandemic.
The lawsuit, filed in federal court in Tampa, Florida, contends that the mask mandate exceeds the authority of the U.S. Centers for Disease Control and Prevention.
A rule of the Centers for Disease Control and Prevention, effective Feb. 1, 2021, requires \u201cthe wearing of masks by people on public transportation conveyances or on the premises of transportation hubs,\u201d according to the agency website. The rule has been relaxed somewhat, to end requirements for certain buses and so forth, but was recently extended until at least April 18 for domestic and international travel in general.
Still, Florida and the other states are pressing on with their lawsuit, which comes amid a partisan divide over the response to the COVID-19 pandemic and issues of government control versus individual rights.<\/p>\n

Read the story here.<\/a><\/em>
A federal judge in Texas is barring the Navy from taking action for now against sailors who have objected to being vaccinated against COVID-19 on religious grounds.
U.S. District Judge Reed O\u2019Connor had in January issued a preliminary injunction preventing the Navy from disciplining or discharging 35 sailors who sued over the Navy\u2019s vaccine policy while their case played out. On Monday, O\u2019Connor agreed the case could go forward as a class action lawsuit and issued a preliminary injunction covering the approximately 4,000 sailors who have objected on religious grounds to being vaccinated.
Defense Secretary Lloyd Austin last year made vaccinations mandatory for service members. More than 99% of the Navy\u2019s active duty force has been vaccinated against COVID-19, and the Navy has also discharged 650 people for refusing to be vaccinated. Navy guidelines allow for exemptions to the vaccine requirement on religious and other grounds, including medical reasons and if a service member is about to leave the Navy.<\/p>\n

Read the story here.<\/a><\/em>
People across Japan are celebrating the peak cherry blossom viewing season one week after the lifting of COVID-19 restrictions, triggering concerns of a possible virus resurgence.
Trees are in full bloom this week in many parts of Japan. The peak in Tokyo was on Sunday, according to the Japan Meteorological Agency, attracting many people who had avoided participating in the national tradition for two years because of the pandemic.
At Chidorigafuchi Park, a famous \u201chanami\u201d or cherry blossom viewing spot northwest of the Imperial Palace, thousands of people viewed the fluffy pale pink flowers while strolling under rows of trees or from rowboats on the palace moat.
\u201cI feel like life has finally gotten back to normal. Here in the downtown area, people have waited for this for so long,\u201d Takanori Shiwaku, a 62-year-old caf\u00e9 owner, said as he admired the blossoms at the park.
He said cherry blossoms, which bloom and then fall en masse, connote a sense of pureness.
\u201cI wanted to come here for sure this year, and I\u2019m really happy,\u201d said Midori Hayashi, a 75-year-old retiree who has largely stayed at home for the past two years.<\/p>\n

Read the story here.<\/a><\/em>
Denmark\u2019s domestic security on Tuesday designated pandemic-linked \u201cantigovernmental extremism\u201d as a menace for the first time ever.
The agency, known by its Danish acronym PET, said in its annual assessment that although this type of extremism is not \u201ca significant driving force for the terrorist threat\u201d in the country, it does make the situation \u201cmore complex.\u201d
PET said the menace which expresses the need to use violence against elected representatives, had appeared in connection with the COVID-19 pandemic.
The general terrorism threat Denmark is \u201cserious\u201d, defined as having the \u201ccapacity, intention and planning,\u201d PET said. Militant Islamism still constitutes the most significant terrorist threat against the Scandinavian country and Danish interests abroad.<\/p>\n

Read the story here.<\/a><\/em>
Chinese authorities sought to reassure companies and jittery investors on Tuesday as a two-phase lockdown of Shanghai\u2019s 26 million people entered its second day, casting an unusual quiet over the normally bustling center of finance, manufacturing and trade.
The omicron outbreak in Shanghai is one of a series across the country that is testing the government\u2019s ability to enforce a strict \u201czero-COVID\u201d strategy without overly disrupting the economy and people\u2019s daily lives.
The shutdown has added to anxiety in financial markets over Russia\u2019s war on Ukraine, the U.S. Federal Reserve\u2019s effort to cool surging inflation by raising interest rates and other challenges facing the global economy.
Market reactions including Monday\u2019s 7% drop in oil prices in London don\u2019t reflect the \u201ctrue reality of the situation,\u201d but investors already were uneasy about China and the global economy, said Michael Every of Rabobank.<\/p>\n

Read the story here.<\/a><\/em>
A former Port Angeles naturopathic physician was sentenced to eight months in prison and one year supervised release after being found guilty of selling products he claimed could prevent numerous serious diseases, including COVID-19.
Richard Marschall, 69, was convicted in 2021, after a four-day trial, of introducing misbranded drugs into interstate commerce, his third conviction, according to the U.S. Attorney\u2019s office.
At the sentencing hearing Monday, U.S. District Judge Benjamin H. Settle said, \u201cIt is extremely dangerous during the COVID epidemic for people to be engaged in conduct that would lead other people to defer and wait to receive medical care.\u201d<\/p>\n

\u201cMr. Marschall has a history of lying to patients about their health and his proposed treatments. His lies in this case are particularly troubling because he employed them when advising others about a deadly pandemic,\u201d said U.S. Attorney Nick Brown. \u201cAs people became fearful and searched for answers, Marschall touted an unproven treatment as a miracle cure for the deadly disease.\u201d<\/p>\n

Read the story here.<\/a><\/em>
U.S. regulators on Tuesday authorized another COVID-19 booster for people age 50 and older, a step to offer extra protection for the most vulnerable in case the coronavirus rebounds.
The Food and Drug Administration\u2019s decision opens a fourth dose of the Pfizer or Moderna vaccines to those people at least four months after their previous booster.
Until now, the FDA had cleared fourth doses only for people 12 and older who have severely weakened immune systems. The agency said this especially fragile group also can get an additional booster, a fifth shot.
The latest expansion, regardless of people\u2019s health, allows an extra shot to millions more Americans \u2014 and the question is whether everyone who\u2019s eligible should rush out and get it. The Centers for Disease Control and Prevention is expected to weigh in.
The move comes at a time of great uncertainty. COVID-19 cases have dropped to low levels after the winter surge of the super-contagious omicron variant. Two vaccine doses plus a booster still provide strong protection against severe disease and death, CDC data show.
Read the story here.<\/a><\/em>
Hong Kong\u2019s deadliest coronavirus outbreak has cost about 6,000 lives this year \u2013 and the city is now running out of coffins.
Authorities have scrambled to order more, with the government saying 1,200 coffins had reached the city last week with more to come.
Space constraints make cremation a common burial practice in the densely populated island territory off the Chinese mainland, and the coffins typically are wood or wood substitutes.
To answer the shortage of them due to the COVID-19 toll, some companies are offering alternatives such as an environmentally friendly cardboard coffin.
LifeArt Asia has cardboard coffins made of recycled wood fiber that can be customized with designs on the exterior. In its factory in Aberdeen, a southern district of Hong Kong, up to 50 coffins can be produced a day.
CEO Wilson Tong said there is still some resistance to using caskets made of cardboard. \u201c(People feel that) it\u2019s a little bit shameful to use so-called paper caskets. They feel that this is not very respectful to their loved ones,\u201d Tong said.
Read the full story here.<\/a><\/em>
Fewer than 800 coronavirus deaths are being reported each day in the United States, the lowest daily average since before the omicron variant took hold late last fall. The last time the rate was this low was in mid-August, according to a New York Times database.
Trends in deaths lag behind cases and hospitalizations by weeks because of the time it takes for people to become seriously ill, and the time needed to complete and file death records.
The seven-day average of new cases has also dropped significantly from the height of the omicron surge. Though the decrease has slowed in recent days, the average has hovered this past week around 30,000 cases per day, a level last seen in July. Coronavirus hospitalizations plummeted in the past two weeks by about 36%, to about 18,000 per day. Intensive care unit hospitalizations have fallen too \u2014 by about 43% \u2014 to under 3,000.
But as cases increased in parts of Europe, scientists and health officials have already been warning of another rise in U.S. cases and, with it, the first major test of the country\u2019s strategy of living with the virus while limiting its effect. Top U.S. health officials reiterated concerns last week about the impact of stalled COVID-19 response aid amid the spread of BA.2, a highly transmissible omicron subvariant accounting for about 35% of new U.S. cases and a form of the virus similar to what swept through the nation this winter.
A growing number of U.S. states are reporting fewer daily updates, saying that metrics like hospitalizations and wastewater monitoring have become more relevant than daily case reports. Still, Kentucky, New York, Colorado and Texas are among a few states that are showing a rise in new cases over the past two weeks.
Read the full story here. <\/a><\/em>
British police are fining 20 people over parties held by Prime Minister Boris Johnson and his staff during coronavirus lockdowns, and say that more people could face penalties.
The Metropolitan Police force said Tuesday it wouldn\u2019t identify the recipients of the fixed penalty notices, though Johnson\u2019s office said it would reveal if he gets one.
Opponents, and some members of the governing Conservative Party, have said that Johnson should resign if he is issued a fine for breaking rules he imposed on the rest of the country during the pandemic.
Dozens of politicians and officials have been investigated over allegations that the government flouted its own pandemic restrictions. Police sent questionnaires to more than 100 people, including the prime minister, and interviewed witnesses as part of the investigation.
Confirming that it had authorized 20 fines, the police force said officers were working through a \u201csignificant amount of investigative material\u201d and more people could face penalties later.
The \u201cpartygate\u201d scandal had left Johnson\u2019s tenure precarious before Russia launched a war in Ukraine more than a month ago that gave Britain\u2019s politicians more urgent priorities.
Read the full story here.<\/a><\/em><\/p>\n

source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Editor\u2019s note: This is a live account of COVID-19 updates from Monday, March 29, as the day unfolded. It is no longer being updated. Click here to see all the most recent news about the pandemic, and click here to find additional resources.The Food and Drug Administration is expected to approve a second booster dose […]<\/p>\n","protected":false},"author":869,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[],"tags":[],"_links":{"self":[{"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/posts\/3089"}],"collection":[{"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/users\/869"}],"replies":[{"embeddable":true,"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/comments?post=3089"}],"version-history":[{"count":0,"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/posts\/3089\/revisions"}],"wp:attachment":[{"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/media?parent=3089"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/categories?post=3089"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/linksus2.linksus.net\/index.php\/wp-json\/wp\/v2\/tags?post=3089"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}